IJNRD Research Journal

WhatsApp
Click Here

WhatsApp editor@ijnrd.org
IJNRD
INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT
International Peer Reviewed & Refereed Journals, Open Access Journal
ISSN Approved Journal No: 2456-4184 | Impact factor: 8.76 | ESTD Year: 2016
Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.76 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)

Call For Paper

For Authors

Forms / Download

Published Issue Details

Editorial Board

Other IMP Links

Facts & Figure

Impact Factor : 8.76

Issue per Year : 12

Volume Published : 9

Issue Published : 96

Article Submitted :

Article Published :

Total Authors :

Total Reviewer :

Total Countries :

Indexing Partner

Join RMS/Earn 300

Licence

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Published Paper Details
Paper Title: Inhibition of Telomerase Activity in Cancer Cell Progression: A Promising Therapeutic Avenue
Authors Name: Sudhanva Devaprasad Dixit
Download E-Certificate: Download
Author Reg. ID:
IJNRD_202161
Published Paper Id: IJNRD2307319
Published In: Volume 8 Issue 7, July-2023
DOI: http://doi.one/10.1729/Journal.35333
Abstract: Telomerase, a specialized reverse transcriptase enzyme, plays a crucial role in maintaining telomere length and cellular immortality. In most somatic cells, telomerase activity is low or absent, leading to progressive telomere shortening with each cell division and eventual cellular senescence. However, in cancer cells, telomerase is frequently reactivated, allowing for indefinite cell division and contributing to tumour growth and progression. Targeting telomerase activity has emerged as a promising therapeutic strategy for cancer treatment. This review study provides an in-depth analysis of the current knowledge on preventing the cancer cell progression by using telomerase inhibitors, focusing on the mechanisms of telomerase inhibitors, preclinical and clinical studies, challenges, and future prospects.
Keywords: Telomeres, Telomerase, cancer, tumour cells, Telomerase inhibitors, Telomerase reverse transcriptase (TERT), telomerase RNA component (TERC)
Cite Article: "Inhibition of Telomerase Activity in Cancer Cell Progression: A Promising Therapeutic Avenue", International Journal of Novel Research and Development (www.ijnrd.org), ISSN:2456-4184, Vol.8, Issue 7, page no.d155-d159, July-2023, Available :http://www.ijnrd.org/papers/IJNRD2307319.pdf
Downloads: 000118768
ISSN: 2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar| ESTD YEAR: 2016
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
Publication Details: Published Paper ID:IJNRD2307319
Registration ID: 202161
Published In: Volume 8 Issue 7, July-2023
DOI (Digital Object Identifier): http://doi.one/10.1729/Journal.35333
Page No: d155-d159
Country: Mysore, Karnataka, India
Research Area: Biological Science
Publisher : IJ Publication
Published Paper URL : https://www.ijnrd.org/viewpaperforall?paper=IJNRD2307319
Published Paper PDF: https://www.ijnrd.org/papers/IJNRD2307319
Share Article:
Share

Click Here to Download This Article

Article Preview
Click Here to Download This Article

Major Indexing from www.ijnrd.org
Semantic Scholar Microsaoft Academic ORCID Zenodo
Google Scholar ResearcherID Thomson Reuters Mendeley : reference manager Academia.edu
arXiv.org : cornell university library Research Gate CiteSeerX PUBLON
DRJI SSRN Scribd DocStoc

ISSN Details

ISSN: 2456-4184
Impact Factor: 8.76 and ISSN APPROVED
Journal Starting Year (ESTD) : 2016

DOI (A digital object identifier)


Providing A digital object identifier by DOI
How to Get DOI? DOI

Conference

Open Access License Policy

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License

Creative Commons License This material is Open Knowledge This material is Open Data This material is Open Content

Important Details

Social Media

Licence

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License

Join RMS/Earn 300

IJNRD